Sarepta Therapeutics | SRPT - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Agios Pharmaceuticals USD -108.66M 11.65M 2026-03
Alnylam Pharmaceuticals USD 245.34M 59.15M 2026-06
Amgen USD 3.86B 1.28B 2026-03
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Capricor Therapeutics USD -27.23M 2.66M 2025-06
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 10.29B 1.86B 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Incyte USD 778.57M 410.6M 2026-06
Insmed USD -148.3M 165.88M 2026-03
Ionis Pharmaceuticals USD -64.53M 135.49M 2026-03
Moderna USD -1.26B 468M 2026-03
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novavax USD 19.36M 190.79M 2025-12
Pfizer USD 6.01B 18M 2026-06
PTC Therapeutics USD 61.98M 132.97M 2026-03
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Roche Holding CHF 13.43B 744M 2026-06
Sanofi EUR 3.69B 375M 2026-06
Sarepta Therapeutics USD 375.48M 627.68M 2026-03
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -155M 55.57M 2026-03
Vertex Pharmaceuticals USD 1.33B 130.5M 2026-06